Literature DB >> 24510832

Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines.

Amir S Khan1, Kate E Broderick, Niranjan Y Sardesai.   

Abstract

The development of effective vaccines has helped to eradicate or control the spread of numerous infectious diseases. However, there are many more diseases that have proved more difficult to eliminate using conventional vaccines. The recent innovation of DNA vaccines may provide a "boost" to the development efforts. While the early efforts of DNA vaccines in the clinic were disappointing, the use of in vivo electroporation has helped to provide some basis for optimism. Now, there are several ongoing clinical studies of vaccines against such diseases as malaria, HIV, hepatitis C, and even various types of cancer. This review will highlight three recently published clinical studies using intramuscular DNA administration with electroporation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510832     DOI: 10.1007/978-1-4614-9632-8_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Trial watch: Naked and vectored DNA-based anticancer vaccines.

Authors:  Norma Bloy; Aitziber Buqué; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

2.  Electroporation of Small Interfering RNAs into Tibialis Anterior Muscles of Mice.

Authors:  Anna Stephan; Flavia A Graca; Liam C Hunt; Fabio Demontis
Journal:  Bio Protoc       Date:  2022-06-05

3.  In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation.

Authors:  Sean Mc Cafferty; Joyca De Temmerman; Tasuku Kitada; Jacob R Becraft; Ron Weiss; Darrell J Irvine; Mathias Devreese; Siegrid De Baere; Francis Combes; Niek N Sanders
Journal:  Mol Ther       Date:  2020-11-11       Impact factor: 11.454

4.  Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques.

Authors:  Shakti Singh; Eric G Ramírez-Salazar; Rami Doueiri; Antonio Valentin; Margherita Rosati; Xintao Hu; Brandon F Keele; Xiaoying Shen; Georgia D Tomaras; Guido Ferrari; Celia LaBranche; David C Montefiori; Jishnu Das; Galit Alter; Hung V Trinh; Christopher Hamlin; Mangala Rao; Frances Dayton; Jenifer Bear; Bhabadeb Chowdhury; Candido Alicea; Jeffrey D Lifson; Kate E Broderick; Niranjan Y Sardesai; Sandra J Sivananthan; Christopher B Fox; Steven G Reed; David J Venzon; Vanessa M Hirsch; George N Pavlakis; Barbara K Felber
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 5.  DNA vaccines: prime time is now.

Authors:  Ebony N Gary; David B Weiner
Journal:  Curr Opin Immunol       Date:  2020-04-04       Impact factor: 7.486

6.  Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults.

Authors:  Srilatha Edupuganti; Stephen C De Rosa; Marnie Elizaga; Yiwen Lu; Xue Han; Yunda Huang; Edith Swann; Laura Polakowski; Spyros A Kalams; Michael Keefer; Janine Maenza; Megan C Wise; Jian Yan; Matthew P Morrow; Amir S Khan; Jean D Boyer; Laurent Humeau; Scott White; Niranjan Y Sardesai; Mark L Bagarazzi; Peter B Gilbert; James G Kublin; Lawrence Corey; David B Weiner
Journal:  Vaccines (Basel)       Date:  2020-12-07

7.  HIV Env conserved element DNA vaccine alters immunodominance in macaques.

Authors:  Xintao Hu; Antonio Valentin; Margherita Rosati; Siriphan Manocheewa; Candido Alicea; Bhabadeb Chowdhury; Jenifer Bear; Kate E Broderick; Niranjan Y Sardesai; Sylvie Le Gall; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2017-07-05       Impact factor: 3.452

8.  DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.

Authors:  Stefan Petkov; Elizaveta Starodubova; Anastasia Latanova; Athina Kilpeläinen; Oleg Latyshev; Simons Svirskis; Britta Wahren; Francesca Chiodi; Ilya Gordeychuk; Maria Isaguliants
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

9.  DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination.

Authors:  Xintao Hu; Antonio Valentin; Yanhui Cai; Frances Dayton; Margherita Rosati; Eric G Ramírez-Salazar; Viraj Kulkarni; Kate E Broderick; Niranjan Y Sardesai; Linda S Wyatt; Patricia L Earl; Bernard Moss; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  Hum Gene Ther       Date:  2018-06-21       Impact factor: 5.695

10.  Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques.

Authors:  Santhi Devasundaram; Margherita Rosati; Antonio Valentin; Svenja Weiss; Vincenza Itri; Hung V Trinh; Jenifer Bear; Bhabadeb Chowdhury; Celia C LaBranche; David Montefiori; Guido Ferrari; Mangala Rao; Xiang-Peng Kong; Susan Zolla-Pazner; George N Pavlakis; Barbara K Felber
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.